The complexity in treatment of patients in shock - EuroPCR 2024

This #europcr 2024 session is essential for those looking to analyze and discuss the findings of the DanGer shock randomized trial, explore the latest evidence in the ACS field such as Horizon, and implement evidence-based practices in peri-procedural planning, execution, drug administration, and weaning strategies to optimize outcomes in acute myocardial infarction complicated by cardiogenic shock, since the session presents the latest data on ECLS and Impella, compares both in shock management, and offers insights on improving survival rates in shock patients, including the latest data on revascularization completeness with percutaneous ventricular assist devices versus IABP.
Sponsored by Abiomed
More videos on: www.pcronline....
#acs
#ami
#cardiogenicshock
#iabp
#ecls